Explore
Companies
Investors
Top 50
Streams
Trending tech news
Latest investments
Latest acquisitions
About Index
Index
By TNW
Log in
Register
NovImmune
225
NovImmune
Technology
Biotechnology
NovImmmune develops therapeutic monoclonal antibodies to treat patients suffering from immune-related disorders.
Suggest edits
Founded
1998
Raised
$137.2M
Follow us
Also headquartered in Geneva
WHO
World Economic Forum
Seedstars
Temenos
ProtonMail
CERN
Seedstars World
IPCC
STMicroelectronics
Silent Circle
Companies in the same industry
MassChallenge
UWI Technology
ChromaDex
Personalis, Inc.
Perlstein Lab
VivoSight OCT
CDx Life
Codagenix
Rubicon Genomics
AlterG
Alexa global traffic share
Overview
Funding
4
Add info
Add round
17 Dec
2010
$22,413,980
Venture capital (Series D)
BZ Bank
12 May
2009
$54,800,000
Venture capital (Series C)
Novartis Venture Fund
,
Aravis Ventures
,
BZ Bank
,
+4
01 Jun
2006
$46,000,000
Venture capital (Series B)
Novartis Venture Fund
,
Aravis Ventures
,
BZ Bank
,
+2
01 May
2000
$14,000,000
Venture capital (Series A)
Novartis Venture Fund
,
LODH Immunology Fund
